JPi Healthcare's DRE Duo: FDA Approval Opens Doors to the U.S. Market

/ News1

(서울=뉴스1) 문대현 기자 = JPi Healthcare, a leading medical imaging company, has successfully launched its digital X-ray system DRE Duo in the U.S. market, marking a significant milestone in its global expansion strategy.

The company announced on Thursday that the DRE Duo system received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on Monday, approximately one year after its initial release in the domestic market.

The DRE Duo is an advanced digital X-ray device that employs cutting-edge low-dose, high-resolution imaging technology. This innovative system minimizes patient radiation exposure while delivering crisp diagnostic images. It streamlines the entire imaging process, from capture to result transmission, and offers versatile installation and operation options to suit various medical settings.

With this FDA clearance, JPi Healthcare is poised to aggressively target global markets, with a particular focus on the United States. The company has already garnered international attention by showcasing its products at major industry events such as RSNA in the U.S., MEDICA in Germany, and WHX in the United Arab Emirates (UAE), setting the stage for substantial export growth.

This latest approval marks JPi Healthcare's second FDA certification, following the success of its veterinary cone beam computed tomography (CT) (CBCT) system, DeteCT Vet. The company is currently seeking FDA approval for its digital tomosynthesis system, StriXion, with the goal of securing clearance by year-end.

Industry analysts are closely watching the potential synergies between JPi Healthcare's new imaging diagnostic equipment and its established X-ray grid business. The company has built a robust international sales network, counting global medical technology giants like GE Healthcare and Siemens among its clientele.

A spokesperson for JPi Healthcare stated that the FDA clearance for DRE Duo is a testament to our imaging technology meeting rigorous global standards. It's leveraging the entry into the U.S. market to expand the digital imaging solutions business and drive international revenue growth.

JPi Healthcare, founded in 1980, boasts a rich legacy in the medical imaging field. In its early years, the company focused on developing domestic alternatives for X-ray components, laying a solid technological foundation.

Throughout the 1990s, JPi Healthcare refined its X-ray grid production technology, solidifying its position in the South Korean market. As the new millennium dawned, the company expanded its product portfolio in response to the burgeoning digital imaging diagnostics market, while simultaneously ramping up its export initiatives.

Over time, JPi Healthcare has steadily expanded its supply chain, forging strategic partnerships with industry leaders such as Siemens in Germany, GE Healthcare in the U.S., and Canon and Fuji Film in Japan. Today, the company collaborates with more than 300 partners across 77 countries worldwide.

This article was originally written in Korean by News1 reporters, translated with AI, and reviewed by editors.

eggod6112@news1.kr